Multiple seropathotypes of verotoxin-producing Escherichia coli (VTEC) disrupt interferon-γ-induced tyrosine phosphorylation of signal transducer and activator of transcription (Stat)-1

Microbial Pathogenesis

Volumn 42, Issue 2-3, 2007, Pages 62-71

  Jandu, Narveen ^a,c   Shen, Songhai ^e   Wickham, Mark E ^d   Prajapati, Rohit ^a   Finlay, Brett B ^d   Karmali, Mohamed A ^e   Sherman, Philip M ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b Departments of Paediatrics   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Laboratory of Foodborne Zoonosis   (Canada)

Author keywords

Enterohemorrhagic; Escherichia coli; Interferon ; Signalling; Stat1; Verotoxin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GAMMA INTERFERON; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; STAT1 PROTEIN; VEROTOXIN; WORTMANNIN;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; EPITHELIUM CELL; ESCHERICHIA COLI O157; GENE ACTIVATION; GENETIC CODE; IMMUNOBLOTTING; INHIBITION KINETICS; INTESTINE CELL; MOLECULAR EVOLUTION; NONHUMAN; PATHOGENICITY; PATHOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; WHOLE CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; CELL LINE, TUMOR; CHROMONES; ENZYME INHIBITORS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOMIC ISLANDS; HUMANS; INTERFERON TYPE II; MORPHOLINES; MUTATION; PHOSPHORYLATION; SHIGA TOXINS; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; STAT1 TRANSCRIPTION FACTOR; TYROSINE; VIRULENCE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 33847149223     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2006.10.005     Document Type: Article

References (38)

1. Rangel J.M., Sparling P.H., Crowe C., Griffin P.M., and Swerdlow D.L. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg Infect Dis 11 (2005) 603-609
2. Karch H., Tarr P.I., and Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 295 (2005) 405-418
3. Karmali M.A. Infection by Shiga toxin-producing Escherichia coli: an overview. Mol Biotechnol 26 (2004) 117-122
4. Cherla R.P., Lee S.Y., and Tesh V.L. Shiga toxins and apoptosis. FEMS Microbiol Lett 228 (2003) 159-166
5. Kaper J.B., Nataro J.P., and Mobley H.L. Pathogenic Escherichia coli. Nat Rev Microbiol 2 (2004) 123-140
6. Law D. Virulence factors of Escherichia coli O157 and other Shiga toxin-producing E. coli. J Appl Microbiol 88 (2000) 729-745
7. Dobrindt U. (Patho-)Genomics of Escherichia coli. Int J Med Microbiol 295 (2005) 357-371
8. Donnenberg M.S., and Whittam T.S. Pathogenesis and evolution of virulence in enteropathogenic and enterohemorrhagic Escherichia coli. J Clin Invest 107 (2001) 539-548
9. Karmali M.A., Mascarenhas M., Shen S., Ziebell K., Johnson S., Reid-Smith R., et al. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 41 (2003) 4930-4940
10. Elliott E.J., Robins-Browne R.M., O'Loughlin E.V., Bennett-Wood V., Bourke J., Henning P., et al. Contributors to the Australian Paediatric Surveillance Unit. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 85 (2001) 125-131
11. Brooks J.T., Sowers E.G., Wells J.G., Greene K.D., Griffin P.M., Hoekstra R.M., et al. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J Infect Dis 192 (2005) 1422-1429
12. Ceponis P.J., McKay D.M., Ching J.C., Pereira P., and Sherman P.M. Enterohemorrhagic Escherichia coli O157:H7 disrupts Stat1-mediated gamma interferon signal transduction in epithelial cells. Infect Immun 71 (2003) 1396-1404
13. Jandu N., Ceponis P.J.M., Kato S., Riff J.D., McKay D., and Sherman P.M. Conditioned medium from enterohemorrhagic Escherichia coli-infected T84 cells inhibits signal transducer and activation of transcription 1 activation by gamma interferon. Infect Immun 74 (2006) 1809-1818
14. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75 (2004) 163-189
15. Igaz P., Toth S., and Falus A. Biological and clinical significance of the JAK-STAT pathway; lessons from knockout mice. Inflamm Res 50 (2001) 435-441
16. Campos L.C., Franzolin M.R., and Trabulsi L.R. Diarrheagenic Escherichia coli categories among the traditional Enteropathogenic E. coli O serogroups-a review. Mem Inst Oswalda Cruz 99 (2004) 545-552
17. Perna N.T., Plunkett Jr. G., Burland V., Mau B., Glasner J.D., Rose D.J., et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409 (2001) 529-533
18. Shen S., Mascarenhas M., Morgan R., Rahn K., and Karmali M.A. Identification of four fimbria-encoding genomic islands that are highly specific for verocytotoxin-producing Escherichia coli serotype O157 strains. J Clin Microbiol 43 (2005) 3840-3850
19. Shen S., Mascarenhas M., Rahn K., Kaper J.B., and Karmali M.A. Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113:H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48. Infect Immun 72 (2004) 1496-1503
20. Kresse A.U., Guzman C.A., and Ebel F. Modulation of host cell signalling by enteropathogenic and Shiga toxin-producing Escherichia coli. Int J Med Microbiol 291 (2001) 277-285
21. Navarro A., Anand-Apte B., Tanabe Y., Feldman G., and Larner A.C. A PI-3 kinase-dependent, Stat1-independent signaling pathway regulates interferon stimulated monocyte adhesion. J Leukoc Biol 73 (2003) 540-545
22. Vlahos C.J., Matter W.F., Hui K.Y., and Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholiny)-8-phenyl-4H-1-benzopyran-one (LY294002). J Biol Chem 269 (1994) 5241-5248
23. Johnson-Henry K., Wallace J.L., Basappa N.S., Soni R., Wu G.K., and Sherman P.M. Inhibition of attaching and effacing lesion formation following enteropathogenic Escherichia coli and Shiga toxin-producing E. coli infection. Infect Immun 69 (2001) 7152-7158
24. Ceponis P.J., McKay D.M., Menaker R.J., Galindo-Mata E., and Jones N.L. Helicobacter pylori infection interferes with epithelial Stat6-mediated interleukin-4 signal transduction independent of cagA, cagE, or VacA. J Immunol 171 (2003) 2035-2041
25. Mitchell D.J., Huynh H.Q., Ceponis P.J., Jones N.L., and Sherman P.M. Helicobacter pylori disrupts STAT1-mediated gamma interferon-induced signal transduction in epithelial cells. Infect Immun 72 (2004) 537-545
26. Decker T., Stockinger S., Karaghiosoff M., Muller M., and Kovarik P. IFNs and Stats in innate immunity to microorganisms. J Clin Invest 109 (2002) 1271-1277
27. Prager R., Annemuller S., and Tschape H. Diversity of virulence patterns among Shiga toxin-producing Escherichia coli from human clinical cases-need for more detailed diagnostics. Int J Med Microbiol 295 (2005) 29-38
28. Beutin L., Kaulfuss S., Herold S., Oswald E., and Schmidt H. Genetic analysis of enteropathogenic amd enterohemorrhagic Escherichia coli serogroup O103 strains by molecular typing of virulence and housekeeping genes and pulse-field gel electrophoresis. J Clin Microbiol 43 (2005) 1552-1563
29. Hayashi T, Makino K, Ohnishi M, Kurokawa K, Ishii K, Yokoyama K, et al. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res 8:11-22 [Erratum in: DNA Res 2001;8:96].
30. Fortune S.M., Solache A., Jaeger A., Hill P.J., Belisle J.T., Bloom B.R., et al. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J Immunol 172 (2004) 6272-6280
31. Cross M.J., Stewart A., Hodgkin M.N., Kerr D.J., and Wakelam M.J. Wortmannin and its structural analogue demethoxyviridin inhibit stimulated phospholipase A2 activity in Swiss 3T3 cells. Wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinase. J Biol Chem 270 (1995) 25352-25355
32. Nakanishi S., Kakita S., Takahashi I., Kawahara K., Tsukuda E., Sano T., et al. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J Biol Chem 267 (1992) 2157-2163
33. Dytoc M.T., Ismaili A., Philpott D.J., Soni R., Brunton J.L., and Sherman P.M. Distinct binding properties of eaeA-negative verocytotoxin-producing Escherichia coli of serotype O113:H21. Infect Immun 62 (1994) 3494-3505
34. Philpott D.J., McKay D.M., Mak W., Perdue M.H., and Sherman P.M. Signal transduction pathways involved in enterohemorrhagic Escherichia coli-induced alterations in T84 epithelial permeability. Infect Immun 66 (1998) 1680-1687
35. Philpott D.J., McKay D.M., Sherman P.M., and Perdue M.H. Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. Am J Physiol 270 (1996) G634-G645
36. McKee M.L., Melton-Celsa A.R., Moxley R.A., Francis D.H., and O'Brien A.D. Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect Immun 63 (1995) 3739-3744
37. Zareie M., Riff J.D., Donato K., McKay D.M., Perdue M.H., Soderholm J.D., et al. Novel Effects of the prototype translocating Escherichia coli, strain C25, on intestinal epithelial structure and barrier function. Cell Microbiol 7 (2005) 1782-1797
38. Colliver J.A., and Markwell S.J. Analysis of covariance in medical research. J Pediatr 111 (1987) 544-545